Clinical trial
Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)
NCT00106938 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 30, 2005
- Completion date
- March 31, 2013
- Enrollment
- 1,663 (actual)
- Sites
- 62
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerosis, carotid artery disease, carotid stenosis, stroke